Optical Systems for In Vivo Molecular Imaging of Cancer

Technology in Cancer Research and Treatment

Volumn 2, Issue 6, 2003, Pages 491-504

  Sokolov, Konstantin ^a   Aaron, Jesse ^e   Hsu, Betsy ^e   Nida, Dawn ^e   Gillenwater, Ann ^a   Follen, Michele ^b   MacAulay, Calum ^c   Adler Storthz, Karen ^a   Korgel, Brian ^e   Descour, Michael ^d   Pasqualini, Renata ^a   Arap, Wadih ^a   Lam, Wan ^c   Richards Kortum, Rebecca ^e  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY OF ARIZONA   (United States)

^e The University of Texas at Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; BIOLOGICAL MARKER; CONTRAST MEDIUM; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR; FLUORESCEIN; FUMAGILLOL CHLOROACETYLCARBAMATE; GELATINASE A; GELATINASE B; GOLD COMPLEX; GREEN FLUORESCENT PROTEIN; INDOCYANINE GREEN; INTEGRIN RECEPTOR; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; MONOCLONAL ANTIBODY; NANOPARTICLE; ONCOPROTEIN; PROTEIN E7; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN P53; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEINASE INHIBITOR; RAS PROTEIN; TELOMERASE; TELOMERASE INHIBITOR; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GROWTH; CELL AGING; CONFOCAL MICROSCOPY; COST BENEFIT ANALYSIS; DNA REPAIR; DRUG CONJUGATION; DRUG TARGETING; FLUORESCENCE ANALYSIS; GENE ACTIVATION; GENE EXPRESSION; GENE LOSS; GENE THERAPY; GENOMICS; HUMAN; IMAGING SYSTEM; IN VIVO STUDY; LASER MICROSCOPY; LIGHT SCATTERING; LUNG NON SMALL CELL CANCER; METASTASIS; MOLECULAR BIOLOGY; NONHUMAN; ONCOGENE; PHAGE DISPLAY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTUM CHEMISTRY; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 9144244922     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460300200602     Document Type: Review

References (112)

1. Organization, W. H. Cancer Control (1996).
2. Frater, J. L. et al. Chronic Myeloid Leukemia Following Therapy with Imatinib Mesylate (Gleevec), Bone Marrow Histopathology and Correlation with Genetic Status. American Journal of Clinical Pathology 119, 833-841 (2003).
3. Yee, K. W. and Keating, A. Advances in Targeted Therapy for Chronic Myeloid Leukemia. Expert Review of Anticancer Therapy 3, 295-310 (2003).
4. Pomper, M. G. Molecular Imaging: An Overview. Academic Radiology 8, 1141-1153 (2001).
5. Rajadhyaksha, M. et al. In Vivo Confocal Scanning Laser Microscopy of Human Skin: Melanin Provides Strong Contrast. Journal of Investigative Dermatology 104, 946-952 (1995).
6. Rajadhyaksha, M., Anderson, R. R., and Webb, R. H. Video-rate Confocal Scanning Laser Microscope for Imaging Human Tissues In Vivo. Applied Optics 38, 2105-2115 (1999).
7. Rajadhyaksha, M. et al. In Vivo Confocal Scanning Laser Microscopy of Human Skin II: Advances in Instrumentation and Comparison with Histology. Journal of Investigative Dermatology, 113, 293-303 (1999).
8. Rajadhyaksha, M. et al. Confocal Examination of Nonmelanoma Cancers in Thick Skin Excisions to Potentially Guide Mohs Micrographic Surgery Without Frozen Histopathology. The Journal of Investigative Dermatology 117, 1137-1143 (2001).
9. Rajadhyaksha, M. et al. Confocal Cross-Polarized Imaging of Skin Cancers to Potentially Guide Mohs Micrographic Surgery. Optics & Photonics News, 30 (2001).
10. Selkin, B. et al. In Vivo Confocal Microscopy in Dermatology. Dermatologic Clinics 19, 369-377 (2001).
11. White, W. M. et al. Noninvasive Imaging of Human Oral Mucosa In Vivo by Confocal Reflectance Microscopy. Laryngoscope 109, 1709-1717 (1999).
12. Gonzalez, S. et al. Confocal Reflectance Imaging of Folliculitis In Vivo: Correlation with Routine Histology. Journal of Cutaneous Pathology 26, 201-205 (1999).
13. González, S. et al. Allergic Contact Dermatitis: Correlation of In Vivo Confocal Imaging to Routine Histology. Journal of the American Academy of Dermatology 40, 708-713 (1999).
14. González, S. et al. Characterization of Psoriasis In Vivo by Reflectance Confocal Microscopy. Journal of Medicine 30, 337-56 (1999).
15. González, S. et al. In Vivo Abnormal Keratinazation in Darier-White's Disease as Viewed by Real-time Confocal Imaging. Journal of Cutaneous Pathology 26, 504-508 (1999).
16. González, S. et al. Confocal Imaging of Sebaceous Gland Hyperplasia In Vivo to Assess Efficacy and Mechanism of Pulsed Dye Laser Treatment. Lasers in Surgery and Medicine 25, 8-12 (1999).
17. Huzaira, M. et al. Topographic Variations in Normal Skin, as Viewed by In Vivo Reflectance Confocal Microscopy. The Journal of Investigative Dermatology 116, 846-852 (2001).
18. Langley, R. G. et al. Confocal Scanning Laser Microscopy of Benign and Malignant Melanocytic Skin Lesions In Vivo. Journal of the American Academy of Dermatology 45, 365-376 (2001).
19. Collier, T. et al. Near Real-Time Confocal Microscopy of Amelanotic Tissue: Detection of Dysplasia in Ex Vivo Cervical Tissue. Academic Radiology 9, 504-512 (2002).
20. Collier, T. et al. Near Real Time Confocal Microscopy of Amelanotic Tissue: Dynamics of Aceto-Whitening Enable Nuclear Segmentation. Optics Express 6, 40-48 (2000).
21. Collier, T. et al. Fiber-Optic Confocal Microscope for Biological Imaging. in Conference on Lasers and Electro-Optics. San Francisco, CA: Institute of Electrical and Electronics Engineers (1998).
22. St Croix, B. et al. Genes Expressed in Human Tumor Endothelium. Science 289, 1197-1202 (2000).
23. Hibi, K. et al. Advances in Brief - Serial Analysis of Gene Expression in Non-Small Cell Lung Cancer. Cancer Research: The Official Organ of the American Association for Cancer Research 58, 5690-5694 (1998).
24. Lal, A. et al. Advances in Brief - A Public Database for Gene Expression in Human Cancers. Cancer Research: The Official Organ of the American Association for Cancer Research 59, 5403-5407 (1999).
25. Kolonin, M., Pasqualini, R., and Arap, W. Molecular Addresses in Blood Vessels as Targets for Therapy. Current Opinion in Chemical Biology 5, 308-313 (2001).
26. Arap, W. et al. Targeting the Prostate for Destruction Through a Vascular Address. Proceedings of the National Academy of Sciences of the United States of America 99, 1527-1531 (2002).
27. Takaha, N. et al. High Mobility Group Protein I(Y): A Candidate Architectural Protein for Chromosomal Rearrangements in Prostate Cancer Cells. Cancer Res. (2002).
28. Condeelis, J. The Biochemistry of Animal Cell Crawling, in Motion Analysis of Living Cells. pp. 85-100. Ed., D. Soll. Wiley Liss, Inc (1988).
29. Bailly, M. et al. Relationship Between Arp2/3 Complex and the Barbed Ends of Actin Filaments at the Leading Edge of Carcinoma Cells after Epidermal Growth Factor Stimulation. J. Cell Biol. (1999).
30. Condeelis, J. S., Wyckoff, J., and Segall, J. E. Imaging of Cancer Invasion and Metastasis using Green Fluorescent Protein. European Journal of Cancer 36, 1671-1680 (2000).
31. Gohongi, T. et al. Tumor-host Interactions in the Gallbladder Suppress Distal Angiogenesis and Tumor Growth: Involvement of Transforming Growth Factor Beta1. Nature Medicine 5, 1203-1208 (1999).
32. Brown, E. B. et al. In Vivo Measurement of Gene Expression, Angiogenesis and Physiological Function in Tumors using Multiphoton Laser Scanning Microscopy. Nature Medicine 7, 864-868 (2001).
33. Carmeliet, P. and Jain, R. K. Angiogenesis in Cancer and other Diseases. Nature 407, 249-257 (2000).
34. van de Vijver, M. J. et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer. The New England Journal of Medicine 347, 1999-2009 (2002).
35. Ang, K. K. et al. Impact of Epidermal Growth Factor Receptor Expression on Survival and Pattern of Relapse in Patients with Advanced Head and Neck Carcinoma. Cancer Research 62, 7350-7356 (2002).
36. Hanahan, D. and Weinberg R. A. The Hallmarks of Cancer. Cell, 100, 57-70 (2000).
37. Lin, C. R. et al. Expression Cloning of Human EGF Receptor Complementary DNA: Gene Amplification and Three Related Messenger RNA Products in A431 Cells.
38. Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A. et al. Human Epidermal Growth Factor Receptor cDNA Sequence and Aberrant Expression of the Amplified Gene in A431 Epidermoid Carcinoma Cells. Nature 309, 418-425 (1984).
39. Xu, Y. H. et al. Human Epidermal Growth Factor Receptor cDNA is Homologous to a Variety of RNAs Overproduced in A431 Carcinoma Cells. Nature 309, 806-810 (1984).
40. Kersemaekers, A. M. et al. Oncogene Alterations in Carcinomas of the Uterine Cervix: Overexpression of the Epidermal Growth Factor Receptor is Associated with Poor Prognosis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5, 577-586 (1999).
41. Chang, J. L. et al. The Expression of Type I Growth Factor Receptors in the Squamous Neoplastic Changes of Uterine Cervix. Gynecologic Oncology 73, 62-71 (1999).
42. Nishioka, T. et al. Prognostic Significance of c-erbB-2 Protein Expression in Carcinoma of the Cervix Treated with Radiotherapy. Journal of Cancer Research and Clinical Oncology 125, 96-100 (1999).
43. Mathevet, P., Frappart, L., and Hittelman, W. Dysplasies du col utérin: étude des expressions des gènes Rb et p53, et corrélation avec l'activité mitotique. Gynecologie, Obstetrique & Fertilite 28, 44-50 (2000).
44. Shin, D. M. et al. Expression of Epidermal Growth Factor Receptor, Polyamine Levels, Ornithine Decarboxylase Activity, Micronuclei, and Transglutaminase I in a 7,12-dimethylbenz(a)anthracene-induced Hamster Buccal Pouch Carcinogenesis Model. Cancer Research 50, 2505-2510 (1990).
45. Todd, R. and D. T. Wong. Epidermal Growth Factor Receptor (EGFR) Biology and Human Oral Cancer. Histology and Histopathology 14, 491-500 (1999).
46. Averbuch, S. D. Lung Cancer Prevention: Retinoids and the Epidermal Growth Factor Receptor-a Phoenix Rising? Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8, 1-3 (2002).
47. Sporn, M. B. The War on Cancer. Lancet 347, 1377-1381 (1996).
48. Thomas, G. T., Lewis, M. P. and Speight, P. M. Matrix Metalloproteinases and Oral Cancer. Oral Oncology 35, 227-33 (1999).
49. Garzetti, G. G. et al. Microinvasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia: Biologic Significance and Clinical Implications of 72-kDa Metalloproteinase Immunostaining. Gynecologic Oncology 61, 197-203 (1996).
50. Talvensaari, A. et al. Matrix Metalloproteinase 2 Immunoreactive Protein Appears Early in Cervical Epithelial Dedifferentiation. Gynecologic Oncology 72, 306-311 (1999).
51. Daneri-Navarro, A. et al. Proteolytic Activity in Extracts of Invasive Cervical Carcinoma and Precursor Lesions. Biomedicine & Pharmacotherapy 49, 304-310 (1995).
52. McCluggage, W. G., Maxwell, P. and Bharucha, H. Immunohistochemical Detection of Metallothionein and MIB1 in Uterine Cervical Squamous Lesions. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 17, 29-35 (1998).
53. Davidson, B. et al. Expression of Matrix Metalloproteinase-9 in Squamous Cell Carcinoma of the Uterine Cervix - Clinicopathologic Study Using Immunohistochemistry and mRNA In Situ Hybridization. Gynecologic Oncology 72, 380-386 (1999).
54. Sienel, W. et al. Prognostic Impact of Matrix Metalloproteinase-9 in Operable Non-small Cell Lung Cancer. International Journal of Cancer 103, 647-651 (2003).
55. Passlick, B. et al. Overexpression of Matrix Metalloproteinase 2 Predicts Unfavorable Outcome in Early-stage Non-small Cell Lung Cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6, 3944-3948 (2000).
56. Hrabec, E. et al. Activity of Type IV Collagenases (MMP-2 and MMP-9) in Primary Pulmonary Carcinomas: A Quantitative Analysis. Journal of Cancer Research and Clinical Oncology 128, 197-204 (2002).
57. Munoz N. HPV and Cervical Neoplasia: Review of Case-control and Cohort Studies. IARC Sci Publ 119, 251-261 (1992).
58. Howett, J. C. Preventing Cervical Cancer. Science 288, 1753-1755 (2000).
59. Klaes, R. et al. Detection of High Risk Cervical Intraepithelial Neoplasia and Cervical Cancer by Amplification of Transcripts Derived from Integrated Papillomavirus Oncogenes. Cancer Research 59, 132-136 (1999).
60. Alberts, B. et al. Molecular Biology of the Cell. New York: Garland Publishing (1994).
61. Drezek, R. A. et al. Laser Scanning Confocal Microscopy of Cervical Tissue Before and After Application of Acetic Acid. American Journal of Obstetrics and Gynecology 182, 1135-1139 (2000).
62. Delaney, P. M. and Harris, M. R. Fiber Optics in Confocal Microscope in Handbook of Confocal Microscopy. pp. 515-523. Ed., Pawley, J. B. Plenum Press: New York (1995).
63. Smithpeter, C. L. et al. Near Real Time Confocal Microscopy of Cultured Amelanotic Cells: Sources of Signal, Contrast Agents, and Limits of Contrast. Journal of Biomedical Optics 3, 429-436 (1998).
64. Minsky, M. Microscopy Apparatus. U. S. Patent 301467 (1961).
65. Liang, C. et al. Design of a High-numerical-aperture Miniature Microscope Objective for an Endoscopic Fiber Confocal Reflectance Microscope. Applied Optics 41, 4603-4610 (2002).
66. Sung, K. B. et al. Near Real Time In Vivo Fibre Optic Confocal Microscopy: Sub-cellular Structure Resolved. Journal of Microscopy 207, 137-145 (2002).
67. Sung, K.-B. et al. Fiber-Optic Confocal Reflectance Microscope With Miniature Objective for In Vivo Imaging of Human Tissues. IEEE Transactions on Biomedical Engineering 49, 1168-1172 (2002).
68. Hornbeck, L. J. Digital Light Processing and MEMS: Reflecting the Digital Display Needs of the Networked Society in SPIE/EOS European Symposium on Lasers, Optics, and Vision for Productivity in Manufacturing 1, Conference on Micro-Optical Tech. For Measurement, Sensors & Microsystems. Besacon, France (1996).
69. Lane, P. M. et al. Medical Optics and Biotechnology - Fiber-optic Confocal Microscopy using a Spatial Light Modulator. Optics Letters 25, 1780-1782 (2000).
70. Benavides, J. M. et al. Multispectral Digital Colposcopy for In Vivo Detection of Cervical Cancer. Optics Express 11, 1223-1236 (2003).
71. Horisberger, M. Colloidal Gold: A Cytochemical Marker for Light and Fluorescent Microscopy and for Transmission and Scanning Electron Microscopy. Scan Electron Microsc 2, 9-31 (1981).
72. Geoghegan, W. D. and Ackerman, G. A. Adsorption of Horseradish Peroxidase, Ovomucoid and Anti-immunoglobulin to Colloidal Gold for the Indirect Detection of Concanavalin A, Wheat Germ Agglutinin and Goat Anti-human Immunoglobulin G on Cell Surfaces at the Electron Microscopic Level: A New Method, Theory and Application. The Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society, 25, 1187-1200 (1977).
73. Mulvaney, P. Surface Plasmon Spectroscopy of Nanosized Metal Particles. Langmuir 12, 788-800 (1996).
74. Nabiev, I. R., Morjani, H. and Manfait, M. Selective Analysis of Antitumor Drug Interaction with Living Cancer Cells as Probed by Surface-enhanced Raman Spectroscopy. European Biophysics Journal 19, 311-316 (1991).
75. Kneipp, K. et al. Surface-Enhanced Raman Spectroscopy in Single Living Cells Using Gold Nanoparticles. Applied Spectroscopy 56, 150-154 (2002).
76. Nie, S. and Emory, S. R. Probing Single Molecules and Single Nanoparticles by Surface-enhanced Raman Scattering. Science 275, 1102-1106 (1997).
77. Elghanian, R. et al. Selective Colorimetric Detection of Polynucleotides Based on the Distance-dependent Optical Properties of Gold Nanoparticles. Science 277, 1078-1080 (1997).
78. Yasuda, R. et al. Resolution of Distinct Rotational Substeps by Submillisecond Kinetic Analysis of F1-ATPase. Nature 410, 898-904 (2001).
79. Schultz, S. et al. Single-target Molecule Detection with Nonbleaching Multicolor Optical Immunolabels. Proceedings of the National Academy of Sciences of the United States of America 97, 996-1001 (2000).
80. Sokolov, K. et al. Real-time Vital Optical Imaging of Precancer using Anti-epidermal Growth Factor Receptor Antibodies Conjugated to Gold Nanoparticles. Cancer Research 63, 1999-2004 (2003).
81. Carpenter, G. Receptors For Epidermal Growth Factor And Other Polypeptide Mitogens. Annual Review of Biochemistry 56, 881-914 (1987).
82. Sokolov, K. et al. Realistic Three-dimensional Epithelial Tissue Phantoms for Biomedical Optics. Journal of Biomedical Optics 7, 148-156 (2002).
83. Hahn-Dantona, E. et al. The Low Density Lipoprotein Receptor-related Protein Modulates Levels of Matrix Metalloproteinase 9 (MMP-9) by Mediating its Cellular Catabolism. The Journal of Biological Chemistry 276, 15498-15503 (2001).
84. Friedl, P., Brocker, E.-B. The Biology of Cell Locomotion within Three-dimensional Extracellular Matrix. Cellular and Molecular Life Sciences 57, 41-64 (2000).
85. Abrams, M. J., Murrer, B. A. Metal Compounds in Therapy and Diagnosis. Science 261, 725-730 (1993).
86. Berkower, I. The Promise and Pitfalls of Monoclonal Antibody Therapeutics. Current Opinion in Biotechnology 7, 622-628 (1996).
87. Holliger, P., Bohlen, H. Engineering Antibodies for the Clinic. Cancer and Metastasis Reviews 18, 411-419 (1999).
88. Weiner, L. M. An Overview of Monoclonal Antibody Therapy of Cancer. Seminars in Oncology 26, 41-50 (1999).
89. Soukos, N. S. et al. Epidermal Growth Factor Receptor-targeted Immunophotodiagnosis and Photoimmunotherapy of Oral Precancer In Vivo. Cancer Research 61, 4490-4496 (2001).
90. Achilefu, S. et al. New Approach to Optical Imaging of Tumors. Proceedings of SPIE: Biomarkers and Biological Spectral Imaging. San Jose, CA (2001).
91. Achilefu, S. et al. Site-specific Tumor Targeted Fluorescent Contrast Agents. Proceedings of SPIE: Clinical Lasers and Diagnostics. Amsterdam (2001).
92. Bugaj, J. E. et al. Novel Fluorescent Contrast Agents for Optical Imaging of In Vivo Tumors Based on a Receptor-targeted Dye-peptide Conjugate Platform. Journal of Biomedical Optics 6, 122-133 (2001).
93. Tung, C. H. et al. A Receptor-targeted Near-infrared Fluorescence probe for In Vivo Tumor Imaging. Chembiochem 3, 784-786 (2002).
94. Becker, A. et al. Receptor-targeted Optical Imaging of Tumors with Near-infrared Fluorescent Ligands. Nature Biotechnology 19, 327-31 (2001).
95. Bremer, C., Tung, C. H. and Weissleder, R. In Vivo Molecular Target Assessment of Matrix Metalloproteinase Inhibition. Nature Medicine 7, 743-748 (2001).
96. Tung, C. H. et al. In Vivo Imaging of Proteolytic Enzyme Activity using a Novel Molecular Reporter. Cancer Research 60, 4953-4958 (2000).
97. Farina, K. L. et al. Cell Motility of Tumor Cells Visualized in Living Intact Primary Tumors using Green Fluorescent Protein. Cancer Research 58, 2528-2532 (1998).
98. Bornhop, D. J. et al. Advance in Contrast Agents, Reporters, and Detection. Journal of Biomedical Optics 6, 106-110 (2001).
99. Desmettre, T., Devoisselle, J. M. and Mordon, S. Fluorescence Properties and Metabolic Features of Indocyanine Green (ICG) as Related to Angiography. Survey of Ophthalmology 45, 15-27 (2000).
100. Slakter, J. S. et al. Indocyanine-green Angiography. Current Opinion in Ophthalmology 6, 25-32 (1995).
101. Haglund, M. M., Berger, M.S. and Hochman, D.W. Enhanced Optical Imaging of Human Gliomas and Tumor Margins. Neurosurgery 38, 308-317 (1996).
102. Anikijenko, P. et al. In Vivo Detection of Small Subsurface Melanomas in Athymic Mice using Noninvasive Fiber Optic Confocal Imaging. The Journal of Investigative Dermatology 117, 1442-1448 (2001).
103. Ito, S. et al. Detection of Human Gastric Cancer in Resected Specimens using a Novel Infrared Fluorescent Anti-human Carcinoembryonic Antigen Antibody with an Infrared Fluorescence Endoscope In Vitro. Endoscopy 33, 849-53 (2001).
104. Banin, U. et al. Size-dependent Electronic Level Structure of InAs Nanocrystal Quantum Dots: Test of Multiband Effective Mass Theory. Journal of Chemical Physics 109, 2306 (1998).
105. Murray, C. B., Norris, D. J. and Bawendi, M. G. Synthesis and Characterization of Nearly Monodisperse CdE (E = Sulfur, Selenium, Tellurium) Semiconductor Nanocrystallites. Journal of the American Chemical Society 115, 8706-8715 (1993).
106. Lacoste, T. D. et al. Ultrahigh-resolution Multicolor Colocalization of Single Fluorescent Probes. Proceedings of the National Academy of Sciences of the United States of America 97, 9461-6 (2000).
107. Chan, W. C. et al. Luminescent Quantum Dots for Multiplexed Biological Detection and Imaging. Current Opinion in Biotechnology 13, 40-46 (2002).
108. Parak, W. J. et al. Cell Motility and Metastatic Potential Studies based on Quantum Dot Imaging of Phagokinetic Tracks. Advanced Materials 14, 882-885 (2002).
109. Akerman, M. E. et al. Nanocrystal Targeting In Vivo. Proceedings of the National Academy of Sciences of the United States of America, 99, 12617-12621 (2002).
110. Dubertret, B. et al. In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles. Science 298, 1759-1762 (2002).
111. Bruchez, M. Jr. et al. Semiconductor Nanocrystals as Fluorescent Biological Labels. Science 281, 2013-2016 (1998).
112. Chan, W. C. and Nie, S. Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection. Science 281, 2016-8 (1998).